Skip to main content

Table 4 Outcome analysis stratified by MAM in the MWA group

From: Stereotactic ablative brachytherapy versus percutaneous microwave ablation as salvage treatments for lung oligometastasis from colorectal cancer

Characteristics

MAM 5–10 mm

(N = 26)

MAM > 10 mm

(N = 22)

P value

LTPFS at 1 year, no. (%)

Yes

No

14 (53.8%)

12 (46.2%)

12 (54.5%)

10 (45.5%)

> 0.99

LTPFS at 3 years, no. (%)

Yes

No

Median LTPFS (months)

OS at 1 year, no. (%)

Yes

No

OS at 3 years, no. (%)

Yes

No

10 (38.5%)

16 (61.5%)

18.4 (95% CI: 8.7–20.6)

18 (69.2%)

8 (30.8%)

12 (46.2%)

14 (53.8%)

10 (45.5%)

12 (54.5%)

19.3 (95% CI: 8.6–21.7)

16 (72.7%)

6 (27.3%)

12 (54.5%)

10 (45.5%)

> 0.99

0.965

> 0.99

> 0.99

Median OS (months)

Complications

Pneumothorax

Bronchopleural fistula

Pleural effusion

Hydropneumothorax

Fever

Total, no. (%)

22.5 (95% CI: 16.1–33.7)

8 (30.8%)

0

2 (7.7%)

0

4 (15.4%)

14 (53.8%)

23.2 (95% CI: 15.8–35.6)

8 (36.4%)

6 (27.3%)

0

2 (9.1%)

2 (9.1%)

18 (81.8%)

0.897

0.211